A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein

Chambers CA, Kuhns MS, Egen JG, Allison JP . CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy Ann Rev Immunol 2001 19: 565–594

Giscombe R, Wang X, Huang D, Lefvert A . CDS1 and promoter single nucleotide polymorphisms of te CTLA-4 gene in Wegener’s Granulomatosis J Rheumatol 2001 in press

Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J . CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2001 2: 145–152

Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K . CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis Tissue Antigens 1998 51: 563–566

Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Garcia-Lozano JR, Nunez-Roldan A . CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis Tissue Antigens 1999 53: 296–300

Harbo HF, Celius EG, Vartdal F, Spurkland A . CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis Tissue Antigens 1999 53: 106–110

Masterma T, Ligers A, Olerup O, Vrethem M, Hillert J . CTLA-4 dimorphisms in gammopathy-associated peripheral neuropathy Eur J Neurol 1999 6: 491–493